Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Deferasirox 180mg film-coated tablets

Active Ingredient:
deferasirox
Company:  
MSN Laboratories Europe Ltd See contact details
ATC code: 
V03AC03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Important information for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
Booklet with detailed information on posology and monitoring of patients on deferasirox, to minimise key adverse effects including medication errors during treatment
{pdf_link}

Important information for Patients

Booklet for patients that have been prescribed deferasirox. It contains important information, including how to take deferasirox the right way, why monitoring of your treatment is important, and which medicines you can take while on deferasirox.
{pdf_link}

Physician´s reference checklist

{healthcare_pro_orange} For Healthcare Professionals
Checklist for deferasirox dosing, dose adjustment and biological monitoring.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

MSN Laboratories Europe Ltd
Company image
Address
Devonshire, Business Centre, Works road, Letchworth Garden City, Herts, SG6 1GJ, UK
WWW
www.msnlabs.com
Telephone
020 3371 7158
Medical Information Direct Line
020 3371 7158
Medical Information e-mail
[email protected]
Customer Care direct line
07831 268 255
Stock Availability
07789 669 333